Browse By Publication: Expert Opinion on Investigational Drugs

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: No Grouping | Volume | Authors/Creators
Number of items: 15.

Doggrell, Sheila (2005) BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opinion on Investigational Drugs, 14(1), pp. 89-91.
Number of citations in Scopus 33
Number of citations in Web of Science® 30

Doggrell, Sheila (2005) Berberine - a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14(5), pp. 683-685.
Number of citations in Scopus 38
Number of citations in Web of Science® 34

Doggrell, Sheila (2005) Farnesoid X receptor agonism - a new approach to the treatment of cholesterol gallstone disease. Expert Opinion on Investigational Drugs, 14(4), pp. 535-538.
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila (2006) Inhibitors of cholesteryl ester transfer protein - a new approach to coronary artery disease. Expert Opinion on Investigational Drugs, 15(2), pp. 99-106.
Number of citations in Scopus 16
Number of citations in Web of Science® 11

Doggrell, Sheila (2005) Is AMN-107 a step forward from imatinib in the treatment of chronic myeloid leukaemia? Expert Opinion on Investigational Drugs, 14(8), pp. 1063-1066.
Number of citations in Scopus 6
Number of citations in Web of Science® 5

Doggrell, Sheila (2005) New drugs being developed for the treatment of tuberculosis. Expert Opinion on Investigational Drugs, 14(7), pp. 917-920.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) Potential of growth hormone-releasing hormone antagonists (JV-1-36 and JV-1-42) for the treatment of brain tumours. Expert Opinion on Investigational Drugs, 14(12), pp. 1561-1564.

Doggrell, Sheila (2005) Rho-kinase inhibitors show promise in pulmonary hypertension. Expert Opinion on Investigational Drugs, 14(9), pp. 1157-1159.
Number of citations in Scopus 24
Number of citations in Web of Science® 20

Doggrell, Sheila (2005) Will the new CB1 cannabinoid receptor antagonist SR-147778 have advantages over rimonabant? Expert Opinion on Investigational Drugs, 14(3), pp. 339-342.
Number of citations in Scopus 13
Number of citations in Web of Science® 7

Doggrell, Sheila (2005) The nitrosterols - a step forward from the steroid anti-inflammatory drugs? Expert Opinion on Investigational Drugs, 14(7), pp. 823-828.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila (2005) A small-molecule lead compound for the treatment of Alzheimer's disease. Expert Opinion on Investigational Drugs, 14(2), pp. 199-201.

Doggrell, Sheila & Hancox, Jules (2005) Ibutilide - recent molecular insights and accumulating evidence for use in atrial flutter and fibrillation. Expert Opinion on Investigational Drugs, 14(5), pp. 655-669.
Number of citations in Scopus 5
Number of citations in Web of Science® 4

Doggrell, Sheila Anne (2010) Resolvin inflammation with pain. Expert Opinion on Investigational Drugs, 19(11), pp. 1461-1464.
Number of full-text downloads 129
Number of citations in Scopus 1
Number of citations in Web of Science® 1

Doggrell, Sheila Anne (2010) The hedgehog pathway inhibitor GDC-0449 shows potential in skin and other cancers. Expert Opinion on Investigational Drugs, 19(3), pp. 451-454.
Number of full-text downloads 248
Number of citations in Scopus 10
Number of citations in Web of Science® 10

Hancox, Jules & Doggrell, Sheila (2010) Perspective: Does ranolazine have potential for the treatment of atrial fibrillation? Expert Opinion on Investigational Drugs, 19(12), pp. 1465-1474.
Number of citations in Scopus 4
Number of citations in Web of Science® 4

This list was generated on Sun Apr 16 13:30:42 2017 AEST.